BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32162750)

  • 1. Patient perspectives on the diagnostic journey to a monogenic diabetes diagnosis: Barriers and facilitators.
    Guan Y; Maloney KA; Pollin TI
    J Genet Couns; 2020 Dec; 29(6):1106-1113. PubMed ID: 32162750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, clinical features and complications of common forms of Maturity Onset Diabetes of the Young (MODY) seen at a tertiary diabetes centre in south India.
    Aarthy R; Aston-Mourney K; Amutha A; Mikocka-Walus A; Anjana RM; Unnikrishnan R; Jebarani S; Venkatesan U; Gopi S; Radha V; Mohan V
    Prim Care Diabetes; 2023 Aug; 17(4):401-407. PubMed ID: 37055265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maturity onset diabetes of the young (MODY) in Chinese children: genes and clinical phenotypes.
    Ming-Qiang Z; Yang-Li D; Ke H; Wei W; Jun-Fen F; Chao-Chun Z; Guan-Ping D
    J Pediatr Endocrinol Metab; 2019 Jul; 32(7):759-765. PubMed ID: 31216263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic counseling in monogenic diabetes GCK MODY.
    Skała-Zamorowska E; Deja G; Borowiec M; Fendler W; Małachowska B; Kamińska H; Młynarski W; Jarosz-Chobot P
    Pediatr Endocrinol Diabetes Metab; 2016; 22(2):54-59. PubMed ID: 28329773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of MODY Probability Calculator in probands of families with early-onset autosomal dominant diabetes from Poland.
    Hohendorff J; Zapala B; Ludwig-Slomczynska AH; Solecka I; Ucieklak D; Matejko B; Mrozinska S; Malecki MT; Szopa M
    Minerva Med; 2019 Dec; 110(6):499-506. PubMed ID: 31638358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetic diagnosis of maturity-onset diabetes of the young (MODY): experiences of patients and family members.
    Bosma AR; Rigter T; Weinreich SS; Cornel MC; Henneman L
    Diabet Med; 2015 Oct; 32(10):1385-92. PubMed ID: 25763774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maturity Onset Diabetes of the Young (MODY) in Tunisia: Low frequencies of GCK and HNF1A mutations.
    Ben Khelifa S; Martinez R; Dandana A; Khochtali I; Ferchichi S; Castaño L
    Gene; 2018 Apr; 651():44-48. PubMed ID: 29408271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing for monogenic diabetes using targeted next-generation sequencing in patients with maturity-onset diabetes of the young.
    Szopa M; Ludwig-Gałęzowska A; Radkowski P; Skupień J; Zapała B; Płatek T; Klupa T; Kieć-Wilk B; Borowiec M; Młynarski W; Wołkow P; Małecki MT
    Pol Arch Med Wewn; 2015; 125(11):845-51. PubMed ID: 26552609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monogenic Childhood Diabetes: Dissecting Clinical Heterogeneity by Next-Generation Sequencing in Maturity-Onset Diabetes of the Young.
    Demirci DK; Darendeliler F; Poyrazoglu S; Al ADK; Gul N; Tutuncu Y; Gulfidan G; Arga KY; Cacina C; Ozturk O; Aydogan HY; Satman I
    OMICS; 2021 Jul; 25(7):431-449. PubMed ID: 34171966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and laboratory clues of maturity-onset diabetes of the young and determination of association with molecular diagnosis.
    Karaoglan M; Nacarkahya G
    J Diabetes; 2021 Feb; 13(2):154-163. PubMed ID: 32710514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.
    Fendler W; Borowiec M; Antosik K; Szadkowska A; Deja G; Jarosz-Chobot P; Mysliwiec M; Wyka K; Pietrzak I; Skupien J; Malecki MT; Mlynarski W
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):321-7. PubMed ID: 21521320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of combined NGS and MLPA genetic tests for differential diagnosis of maturity onset diabetes of the young.
    Komazec J; Zdravkovic V; Sajic S; Jesic M; Andjelkovic M; Pavlovic S; Ugrin M
    Endokrynol Pol; 2019; 70(1):28-36. PubMed ID: 30259503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A decision algorithm to identify patients with high probability of monogenic diabetes due to HNF1A mutations.
    Szopa M; Klupa T; Kapusta M; Matejko B; Ucieklak D; Glodzik W; Zapala B; Sani CM; Hohendorff J; Malecki MT; Skupien J
    Endocrine; 2019 Apr; 64(1):75-81. PubMed ID: 30778899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision diabetes: Lessons learned from maturity-onset diabetes of the young (MODY).
    Tosur M; Philipson LH
    J Diabetes Investig; 2022 Sep; 13(9):1465-1471. PubMed ID: 35638342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MODY in Ukraine: genes, clinical phenotypes and treatment.
    Globa E; Zelinska N; Elblova L; Dusatkova P; Cinek O; Lebl J; Colclough K; Ellard S; Pruhova S
    J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1095-1103. PubMed ID: 28862987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approach to the Patient with MODY-Monogenic Diabetes.
    Broome DT; Pantalone KM; Kashyap SR; Philipson LH
    J Clin Endocrinol Metab; 2021 Jan; 106(1):237-250. PubMed ID: 33034350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next generation sequencing targeted gene panel in Greek MODY patients increases diagnostic accuracy.
    Tatsi EB; Kanaka-Gantenbein C; Scorilas A; Chrousos GP; Sertedaki A
    Pediatr Diabetes; 2020 Feb; 21(1):28-39. PubMed ID: 31604004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maturity Onset Diabetes of the Young due to Glucokinase, HNF1-A, HNF1-B, and HNF4-A Mutations in a Cohort of Turkish Children Diagnosed as Type 1 Diabetes Mellitus.
    Ozsu E; Cizmecioglu FM; Yesiltepe Mutlu G; Yuksel AB; Calıskan M; Yesilyurt A; Hatun S
    Horm Res Paediatr; 2018; 90(4):257-265. PubMed ID: 30481753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maturity-onset diabetes of the young in a large Portuguese cohort.
    Santos Monteiro S; da Silva Santos T; Fonseca L; Assunção G; Lopes AM; Duarte DB; Soares AR; Laranjeira F; Ribeiro I; Pinto E; Rocha S; Barbosa Gouveia S; Vazquez-Mosquera ME; Oliveira MJ; Borges T; Cardoso MH
    Acta Diabetol; 2023 Jan; 60(1):83-91. PubMed ID: 36208343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of hepatic nuclear factor 1A monogenic diabetes mellitus (HNF1A-MODY) impacts antihyperglycemic treatment.
    Schnedl WJ; Holasek SJ; Schenk M; Enko D; Mangge H
    Wien Klin Wochenschr; 2021 Mar; 133(5-6):241-244. PubMed ID: 33245425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.